To date, mutations in the ABCP have been associated with cancer chemotherapy drug resistance [41, 42], atherosclerosis, inflammation [43], and several other diseases [43–45], while disorders linked to ATP7A include Menkes disease and occipital horn syndrome [46, 47]. This evidence concerns the gene ATP7A and occipital horn syndrome.